Incidence and risk factors of severe adverse events with nevirapine-based antiretroviral therapy in HIV-infected women. MTCT-Plus program, Abidjan, Côte d'Ivoire

<p>Abstract</p> <p>Background</p> <p>In resource-limited settings where nevirapine-containing regimen is the preferred regimen in women, data on severe adverse events (SAEs) according to CD4 cell count are limited. We estimated the incidence of SAEs according to CD4 cell count and identify their ris...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Amani-Bosse Clarisse, Tanon Aristophane K, Tonwe-Gold Besigin, Coffie Patrick A, Bédikou Gédéon, Abrams Elaine J, Dabis François, Ekouevi Didier K
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	BMC 2010-06-01
Sarja:	BMC Infectious Diseases
Linkit:	http://www.biomedcentral.com/1471-2334/10/188
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!